Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

App aims to make healthy living easier

NCT ID NCT06191822

First seen Jun 06, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This completed pilot study tested the Aspire2B mobile app's technical features, such as connecting to wearable devices, setting personalized nutrition, fitness, and sleep goals, and tracking progress. Over 1,700 participants used the app to see if it worked as intended. The goal was to gather information to improve future versions of the app.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIFESTYLE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Remote, no facility visits. Managed by PepsiCo R&D Life Sciences

    Chicago, Illinois, 60661, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mobile app (Aspire2B) with personalized nutrition, fitness, and sleep goals

What this could lead to

If successful, this could help improve future versions of the app for tracking lifestyle goals.

What could go wrong

This is a small pilot study focused on app performance, not health outcomes. It may not lead to any direct health benefits.

Conditions

The condition(s) this trial relates to.

Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.